Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy: A Schedule or a Dose Issue?-Reference-Cited by-同舟云学术

Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy: A Schedule or a Dose Issue?

Published:2007-04 Issue:7 Volume:7 Page:550-554
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Pace Andrea,Nisticó Cecilia,Cuppone Federica,Bria Emilio,Galié Edvina,Graziano Giuliana,Natoli Guido,Sperduti Isabella,Jandolo Bruno,Calabretta Francesca,Tomao Silverio,Terzoli Edmondo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Paclitaxel neurotoxicity: clinical and neurophysiological study in 23 patients;Pace;It J Neurol Sci,1996

2. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies;Chaudry;Ann Neurol,1994

3. Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug taxol: a review;Guchelaar;Clin Oncol (R Coll Radiol),1994

4. Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes;Mielke;Eur J Cancer,2006

5. Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and Leukemia Group B trial 9342;Winer;J Clin Oncol,2004

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Otoprotective Mechanisms of Carvone As An Antioxidant Agent Against Ototoxic Damage Caused By Paclitaxel;Clinical and Experimental Health Sciences;2023-12-29

2. 7-Chloro-4-(Phenylselanyl) Quinoline Is a Novel Multitarget Therapy to Combat Peripheral Neuropathy and Comorbidities Induced by Paclitaxel in Mice;Molecular Neurobiology;2022-08-15

3. Paklitakselin neden olduğu oksidatif hasara karşı farnesenin otoprotektif etkileri;Cukurova Medical Journal;2022-06-30

4. Inhibitors of Mitochondrial Human Carbonic Anhydrases VA and VB as a Therapeutic Strategy against Paclitaxel-Induced Neuropathic Pain in Mice;International Journal of Molecular Sciences;2022-06-02

5. Symptom status, body perception, and risk of anxiety and depression in breast cancer patients receiving paclitaxel: a prospective longitudinal study;Supportive Care in Cancer;2021-10-17